{"date":"2026-10-13","count":12,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4743-2026-10-13-2228-1ufh2qj","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-10-13","time":"22:28:41","subject":"公告本公司 Bonvadis 外用乳膏，取得巴西衛生監督局(ANVISA)核准完全傷口適應症之醫材上市許可","clause":"第10款","fact_date":"2026-10-13","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-10-13 22:28，「公告本公司 Bonvadis 外用乳膏，取得巴西衛生監督局(ANVISA)核准完全傷口適應症之醫材上市許可」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-10-13-2003-uuu14j","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-10-13","time":"20:03:56","subject":"中裕新藥將於IDWeek2026發表兩項臨床研究成果聚焦TMB-365/TMB-380長效HIV抗體療法之抗藥性潛力與TMB-365單劑量安全性及藥物動力學","clause":"第53款","fact_date":"2026-10-13","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-10-13 20:03，「中裕新藥將於IDWeek2026發表兩項臨床研究成果聚焦TMB-365/TMB-380長效HIV抗體療法之抗藥性潛力與T」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-10-13-1750-11s32v6","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-10-13","time":"17:50:10","subject":"公告本公司及子公司多模式(股)公司與聯貸銀行團簽訂聯合授信合約","clause":"第10款","fact_date":"2026-10-13","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-10-13 17:50，「公告本公司及子公司多模式(股)公司與聯貸銀行團簽訂聯合授信合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-10-13-1731-jc8s5h","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-10-13","time":"17:31:46","subject":"代重要子公司久和醫療儀器(股)公司公告背書保證餘額達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第四款之公告標準","clause":"第22款","fact_date":"2026-10-13","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-10-13 17:31，「代重要子公司久和醫療儀器(股)公司公告背書保證餘額達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第四款之公」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-10-13-1731-firf49","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-10-13","time":"17:31:29","subject":"本公司背書保證餘額達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第四款之公告標準","clause":"第22款","fact_date":"2026-10-13","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-10-13 17:31，「本公司背書保證餘額達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第四款之公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-10-13-1725-p67uuk","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-10-13","time":"17:25:53","subject":"公告本公司內部稽核主管異動","clause":"第11款","fact_date":"2026-10-13","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-10-13 17:25，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-10-13-1622-1sf6mcn","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-10-13","time":"16:22:31","subject":"公告本公司買回公司股份期間屆滿及執行情形","clause":"第35款","fact_date":"2026-10-13","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-10-13 16:22，「公告本公司買回公司股份期間屆滿及執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-10-13-1543-1vmbsc4","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-10-13","time":"15:43:37","subject":"公告本公司115年現金增資訂定認股基準日相關事宜(補充公告發行價格暨代收股款及存儲價款機構)","clause":"第9款","fact_date":"2026-10-13","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-10-13 15:43，「公告本公司115年現金增資訂定認股基準日相關事宜(補充公告發行價格暨代收股款及存儲價款機構)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-10-13-1525-pm5jnl","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-10-13","time":"15:25:11","subject":"公告本公司經主管機關核備115年現金增資調整發行價格","clause":"第44款","fact_date":"2026-10-13","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-10-13 15:25，「公告本公司經主管機關核備115年現金增資調整發行價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4194-2026-10-13-1444-17zi8de","company_id":"4194","company":"禾生技","market":"興櫃","industry":"生技醫療","date":"2026-10-13","time":"14:44:34","subject":"更正-本公司115年現金增資收足股款暨增資基準日","clause":"第44款","fact_date":"2026-10-13","cite_as":"公開資訊觀測站重大訊息：禾生技（4194），2026-10-13 14:44，「更正-本公司115年現金增資收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4194-2026-10-13-1123-1752vc6","company_id":"4194","company":"禾生技","market":"興櫃","industry":"生技醫療","date":"2026-10-13","time":"11:23:03","subject":"本公司115年現金增資股款催繳公告","clause":"第44款","fact_date":"2026-10-13","cite_as":"公開資訊觀測站重大訊息：禾生技（4194），2026-10-13 11:23，「本公司115年現金增資股款催繳公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4194-2026-10-13-1122-1poif10","company_id":"4194","company":"禾生技","market":"興櫃","industry":"生技醫療","date":"2026-10-13","time":"11:22:29","subject":"本公司115年現金增資收足股款暨增資基準日","clause":"第44款","fact_date":"2026-10-13","cite_as":"公開資訊觀測站重大訊息：禾生技（4194），2026-10-13 11:22，「本公司115年現金增資收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}